Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of SR1375 in hospitalized adults with community-acquired pneumonia
CTR20242885Phase 2Active
- Sponsor
- SimuRoad Biotechnology
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SR1375 in community-acquired pneumonia (CAP), sponsored by SimuRoad Biotechnology. Started Sep 2024; status: active.
02
Drugs
SR1375
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20242885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242885.